[{"NetIncomeLossConverted_1_Q1_USD":-35504000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-15682000.0,"CommonStockSharesOutstanding_0_Q1_shares":49117040.0,"StockholdersEquity_0_Q1_USD":1101165000.0,"EarningsPerShareBasic_1_Q1_USD":-0.73,"RevenuesConverted_1_Q1_USD":25205000.0,"Assets_0_Q1_USD":1127584000.0,"CommonStockSharesConverted_0_Q1_shares":49117040.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]